BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2018

  As of January 31, 2018, shares and voting rights outstanding of Essilor, the world leader in ophthalmic optics, broke down as follows:

  February 7, 2018

   · 

  1 min read
• 

  Deals

  Allergan Snaps Up Sydney Biotech for Upfront Payment of US $95M

  Elastagen’s revolutionary technology is based on recombinant human tropoelastin, the precursor of elastin which is a key component of youthful skin.

  February 7, 2018

   · 

  4 min read
• Drug Development

  Synairgen Phase II Clinical Trial Commences Dosing in Patients With COPD

  Synairgen today announces that the first patients have been dosed in the Company’s Phase II trial of inhaled SNG001 in patients with chronic obstructive pulmonary disease.

  February 7, 2018

   · 

  2 min read
• Business

  Alkermes to Host Conference Call to Discuss Fourth Quarter and Year-End 2017 Financial Results

  The webcast player and accompanying slides may be accessed on the Investors section of Alkermes’ website at www.alkermes.com.

  February 7, 2018

   · 

  1 min read
• Business

  Nuvasive Announces Conference Call and Webcast of Fourth Quarter and Full Year 2017 Results

  NuVasive will hold a conference call on Monday, February 26, 2018, at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results of its financial performance for the fourth quarter and full year 2017.

  February 7, 2018

   · 

  2 min read
• Business

  Biostage Names Jason Chen Chairman of its Board of Directors

  Mr. Chen is a broadly skilled senior executive with over 20 years of leadership experience in global commerce and advancing foreign corporate interests in China.

  February 7, 2018

   · 

  6 min read
• Business

  InfuSystem Holdings Reports Interim CFO Will Leave Company at End of Current Quarter

  Mr. Downs resignation does not reflect any dispute or disagreement with the Company, nor does it relate to any issues with respect to the Company’s financial performance.

  February 7, 2018

   · 

  4 min read
• Business

  Lannett Announces Fiscal 2018 Second-Quarter Financial Results; Reports Record Revenues, Strong Earnings

  Lannett today reported financial results for its fiscal 2018 second quarter ended December 31, 2017.

  February 7, 2018

   · 

  65 min read
• 

  Cancer Biotech Novocure Scores New $150M Debt Financing

  The cash will be used to to execute core strategies of driving commercial adoption of Optune and advancing the clinical pipeline.

  February 7, 2018

   · 

  3 min read
• Business

  ViewRay Appoints Scott Huennekens and Daniel Moore to its Board of Directors

  The Company also announced the impending resignations of two directors: David Bonita, M.D., and Mark S. Gold, M.D. Both Dr. Bonita and Dr. Gold announced their intention to step down from the Board at the Company’s Annual Meeting.

  February 7, 2018

   · 

  4 min read